The World Health Organization agrees to the legal compulsory pandemic agreement

The members of the World Health Organization (WHO) accepted the text of the legal compulsory contract prepared to better solve future pandems.

The Pact is designed to prevent inconvolution and competition for the sources taken during the COVID-19.

The main elements include rapid share of new diseases for rapid share, scientists and pharmaceutical companies for new diseases and pharmaceutical companies to work faster for the development of treatment and vaccinations.

For the first time, it will also provide information on global supply chains for masks, medical gowns and other personal protective equipment (PPE).

Director General Dr. Tedros Adhanom Ghebreyesus described the deal as a “significant stage in a traveler shared journey to a safer world.”

“(Member States) also demonstrated that the multilateral problem was vibrant and good, and the people around the divided world can still react to the common space and shared threats,” he said.

On Wednesday, the legitimate compulsory pact came after three years of talks between the member states.

This is the only second time in the 75-year history, this type is only the second time in 2003 – 2003 – 2003 is a tobacco control deal.

When I met for the World Health Assembly next month, it must be officially adopted by members.

In the United States, the US Dediad Trump did not have a part of the recent discussions after the decision of the Global Health Agency, and the United States will not be connected in 2026.

According to the agreed conditions, countries will have to ensure that pandemic related drugs are available in the world.

The participants will have to allocate 20% of vaccine, therapeutic and diagnostic production. At least 10% will have to be forgiven with the remaining prices.

The countries also confirmed the transfer of health technologies to poor nations until the “mutual agreement”.

This should allow more local vaccine and drug production during the pandemic. But this item was extremely controversial.

Developing countries are angry with the wealthy peoples and vaccines during the Covid-19, the countries of the large drug industry can damage research and development.

The proposed pathogen entry and benefit sharing system (PABS) offered based on the agreement allows you to exchange faster information among pharmaceutical companies.

These companies must start to start working on new medicines in any future.